Omipalisib Uses, Dosage, Side Effects and more
Omipalisib has been used in trials studying the treatment of CANCER, Solid Tumours, and Idiopathic Pulmonary Fibrosis.
| Trade Name | Omipalisib |
| Generic | Omipalisib |
| Omipalisib Other Names | Omipalisib |
| Type | |
| Formula | C25H17F2N5O3S |
| Weight | Average: 505.496 Monoisotopic: 505.102016535 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
